This is especially important for neurologists, as patients with focal neurologic symptoms due to acute aortic dissections who receive thrombolysis with recombinant tissue plasminogen activator (r-TPA) have a 71% mortality rate (7, 8). The gene discussed is PLAT; the disease is Aortic dissection.